Scientific Online Resource System

Varna Medical Forum

Contemporary management of Burning Mouth Syndrome

Mario Milkov, Plamen Nedev, Tsvetan Tonchev, Hristina Madzhova

Abstract

Burning mouth syndrome is characterized by a bilateral burning sensation in the oral mucosa and perioral areas, taste disorders, oral dryness and absent objective findings. It is difficult to diagnose and manage as well. Three main therapeutic approaches are nowadays used: behavioural interventions, topical medications and systemic medications. The first one includes cognitive behavioural therapy, group psychotherapy and electroconvulsive therapy. Topical drugs belong to several groups such as benzodiazepines, anesthetics, atypical analgesics, tricyclic antidepressants, nonsteroidal anti-inflammatory drugs, antimicrobials and mucosal protectors. System drugs additionally include anticonvulsants, selective inhibitors the reuptake of serotonin and norepinepherine, antioxidants, dopamine agonists, histamine-2 receptor antagonists, herbal medicines and salivary stimulants as well. Lowenergy laser therapy can be successfully applied, too.

Full Text


References

Amos, K., S. C. Yeoh, C. S. Farah. Combined topical and systemic clonazepam therapy for the management of burning mouth syndrome: a retrospective pilot study.- J. Orofac. Pain, 25, 2011, No 2, 125-130.

Cavalcanti, D. R., F. R. da Silveira. Alpha lipoic acid in burning mouth syndrome - a randomized double-blind placebo-controlled trial.- J. Oral Pathol. Med., 38, 2009, No 3, 254-261.

Campisi, G., F. Spadari, A. Salvato. Il sucralfato in odontostomatologia.- Minerva Stomatol., 26, 1997, No 6, 297-305.

Cho, G. S., M. W. Han, B. Lee, J. L. Roh, S. H. Choi, K. J. Cho, et al. Zinc deficiency may be a cause of burning mouth syndrome as zinc replacement therapy has therapeutic effects.- J. Oral Pathol. Med., 39, 2010, No 9, 722-727.

de Moraes, M., B. A. do Amaral Bezerra, P. C. da Rocha Neto, A. C. de Oliveira Soares, L. P. Pinto, A. de Lisboa Lopes Costa. Randomized trials for the treatment of burning mouth syndrome: an evidence-based review of the literature.- J. Oral Pathol. Med., 41, 2012, No 4, 281-287.

Demarosi, F., M. Tarozzi, G. Lodi, L. Canegallo, L. Rimondini, A. Sardella. The effect of levosulpiride in burning mouth syndrome.- Minerva Stomatol., 56, 2007, No 1-2, 21-26.

dos Santos Lde, F., A. Carvalho Ade, J. C. Leao, D. E. Cruz Perez, J. F. Castro. Effect of low- level laser therapy in the treatment of burning mouth syndrome: a case series.- Photomed. Laser Surg., 29, 2011, No 12, 793-796.

Femiano, F., F. Gombos, C. Scully. Burning Mouth Syndrome (BMS): open trial of psychotherapy alone, medication with alpha- lipoic acid (thioctic acid), and combination therapy.- Oral. Med. Pathol., 9, 2004, No 1, 8-13.

Femiano, F., F. Gombos, C. Scully. Burning mouth syndrome: the efficacy of lipoic acid on subgroups.- J. Eur. Acad. Dermatol. Venereol., 18, 2004a, No 6, 676-678.

Gremeau-Richard, C., A. Woda, M. L. Navez, N. Attal, D. Bouhassira, M. C. Gagnieu, et al. Topical clonazepam in stomatodynia: a randomised placebo-controlled study.- Pain, 108, 2004, No 1-2, 51-57.

Grushka, M., J. Epstein, A. Mott. An open label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome.- Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 86, 1998, No 5, 557-561.

Heckmann, S. M., J. G. Heckmann, A. Ungethum, P. Hujoel, T. Hummel. Gabapentin has little or no effect in the treatment of burning mouth syndrome - results of an open-label pilot study.- Eur. J. Neurol., 13, 2006, No 1, 6-7.

Heckmann, S. M., E. Kirchner, M. Grushka, M. G. Wichmann, T. Hummel. A double-blind study on clonazepam in patients with burning mouth syndrome.- Laryngoscope, 122, 2012, No 4, 813-816.

Kato, Y., T. Sato, A. Katagiri A, Umezaki Y, Takenoshita M, Yoshikawa T, et al. Milnacipran dose-effect study in patients with burning mouth syndrome.- Clin. Neuropharmacol., 34, 2011, No 4, 166-169.

Klasser, G. D., J. B. Epstein, D. Villines. Management of burning mouth syndrome.- J. Can. Dent. Assoc., 77, 2011, b151.

Ko, J. Y., M. J. Kim, S. G. Lee, H. S. Kho. Outcome predictors affecting the efficacy of clonazepam therapy for the management of burning mouth syndrome (BMS).- Arch. Gerontol. Geriatr., 55, 2012, No 3, 755-761.

Levy, L. M., R. I. Henkin. Human taste phantoms can be related to specific regional areas of decreased brain Æ’Ã-aminobutyric acid (GABA) by magnetic resonance spectroscopy (MRS).- J. Investig. Med., 46, 1998, Abstract p. 219.

Lopez-Dfalessandro, E., L. Escovich. Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of burning mouth syndrome: a randomized, double-blind, placebo controlled trial.- Med. Oral Patol. Oral Cir. Bucal., 16, 2011, No 5, E635-E640.

Lopez-Jornet, P., F. Camacho-Alonso, P. Andujar-Mateos, M. Sanchez-Siles, F. Gomez-Garcia. Burning mouth syndrome: an update.- Med. Oral Patol. Oral Cir. Bucal., 15, 2010, No 4, E562-E568.

Maina, G., A. Vitalucci, S. Gandolfo, F. Bogetto. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study.- J. Clin. Psychiatry, 63, 2002, No 1, 38-43.

Marino, R., S. Torretta, P. Capaccio, L. Pignataro, F. Spadari. Different therapeutic strategies for burning mouth syndrome: preliminary data.- J. Oral Pathol. Med., 39, 2010, No 8, 611-616.

Minguez-Sanz, M. P., C. Salort-Llorca, F. J. Silvestre-Donat. Etiology of burning mouth syndrome: a review and update.- Med. Oral Patol. Oral Cir. Bucal., 16, 2011, No 2, E144-E148.

Minor, J. S., J. B. Epstein. Burning mouth syndrome and secondary oral burning.- Otolaryngol. Clin. North Am., 44, 2011, No 1, 205-219, vii.

Mock, D., D. Chugh. Burning mouth syndrome.- Int. J. Oral Sci., 2, 2010, No 1, 1-4.

Petruzzi, M., D. Lauritano, M. De Benedittis, M. Baldoni, R. Serpico. Systemic capsaicin for burning mouth syndrome: short- term results of a pilot study.- J. Oral Pathol. Med., 33, 2004, No 2, 111-114.

Pezelj-Ribari., S., L. Kqiku, G. Brumini, M. M. Urek, R. Antoni., Kui. D, et al. Proinflammatory cytokine levels in saliva in patients with burning mouth syndrome before and after treatment with low-level laser therapy.- Lasers Med. Sci., 28, 2013, No 1, 297-301.

Rodriguez-Cerdeira, C., E. Sanchez- Blanco. Treatment of burning mouth syndrome with amisulpride.- J. Clin. Med. Res., 4, 2012, No 3, 167-171.

Rojo, L., F. J. Silvestre, J. V. Bagan, T. De Vicente. Psychiatric morbidity in burning mouth syndrome. Psychiatric interview versus depression and anxiety scales.- Oral Surg. Oral Med. Oral Pathol., 75, 1993, No 3, 308-311.

Sardella, A., D. Uglietti, F. Demarosi, G. Lodi, C. Bez, A. Carrassi. Benzydamine hydrochloride oral rinses in management of burning mouth syndrome. A clinical trial.- Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 88, 1999, No 6, 683-686.

Spanemberg, J. C., K. Cherubini, M. A. de Figueiredo, A. P. Gomes, M. M. Campos, F. G. Salum. Effect of an herbal compound for treatment of burning mouth syndrome: randomized, controlled, double-blind clinical trial.- Oral Surg. Oral Med. Oral Pathol. Oral Radiol., 113, 2012, No 3, 373-377.

Spanemberg, J. C., K. Cherubini, M. A. de Figueiredo, L. S. Yurgel, F. G. Salum. Aetiology and therapeutics of burning mouth syndrome: an update.- Gerodontology, 29, 2012Ã , No 2, 84-89.

Stuginski-Barbosa, J., G. G. Rodrigues, M. E. Bigal, J. G. Speciali. Burning mouth syndrome responsive to pramipexol.- J. Headache Pain, 9, 2008, No 1, 43-45.

Sugimoto, K. The dubious effect of milnacipran for the treatment of burning mouth syndrome.- Clin. Neuropharmacol., 34, 2011, No 4, 170-173.

Tammiala-Salonen, T., H. Forssell. Trazodone in burning mouth pain: a placebo-controlled, double-blind study.- J. Orofac. Pain, 13, 1999, No 2, 83-88.

Tatullo, M., M. Marrelli, S. Scacco, M. Lorusso, S. Doria, R. Sabatini, et al. Relationship between oxidative stress and “burning mouth syndrome” in female patients: a scientific hypothesis.- Eur. Rev. Med. Pharmacol. Sci., 16, 2012, No 9, 1218-1221.

Woda, A., M. L. Navez, P. Picard, C. Gremeau, E. Pichard-Leandri. A possible therapeutic solution for stomatodynia (burning mouth syndrome).- J. Orofac. Pain, 12, 1998, No 4, 272-278.

Yan, Z., N. Ding, H. Hua. A systematic review of acupuncture or acupoint injection for management of burning mouth syndrome.- Quintessence Int., 43, 2012, No 8, 695-701.

Yang, H. W., Y. F. Huang. Treatment of burning mouth syndrome with a low- level energy diode laser.- Photomed. Laser Surg., 29, 2011, No 2, 123-125.

Zur, E. Burning mouth syndrome: a discussion of a complex pathology.- Int. J. Pharm. Compd., 16, 2012, No 3, 196-205.




DOI: http://dx.doi.org/10.14748/vmf.v2i1.1080

Refbacks

Font Size


|